跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMGLIDIA 0,6 mg/ml SUSPENSION ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
AMGLIDIA 0,6 mg/ml SUSPENSION ORAL
Approved
STANDARD
AMGLIDIA 0,6 mg/ml SUSPENSION ORAL
Ammtek
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 14, 2021
Approval ID
d7910680fd6c8a00
Company
Ammtek
Type
Standard
Approval Details
Approval Id
d7910680fd6c8a00
Drug Cima Aemps Name
AMGLIDIA 0,6 mg/ml SUSPENSION ORAL
Register Number
1181279001
Holder Company Name
Ammtek
Marketing Company Name
Bioprojet Pharma
Holder Company Detail Path
/organization/ammtek-ltd
Marketing Company Detail Path
/organization/bioprojet-pharma
Authorization Date
2021-01-14
Dosage Form
SUSPENSIÓN ORAL
Dose
0,6 mg/ml
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Ammtek
Company Detail Path
/organization/ammtek-ltd
Company Information
Pharmaceutical Company Name
Ammtek Ltd.
Active Ingredients
GLIBENCLAMIDA
18 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 14, 2021
Approval ID
d7910680fd6c8a00
Type
Standard
Back to CIMA-AEMPS Approvals